Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance
ABSTRACT Cryptococcal meningitis is a lethal disease with few therapeutic options. Induction therapy with fluconazole has been consistently demonstrated to be associated with suboptimal microbiological and clinical outcomes. Exposure to fluconazole causes dynamic changes in antifungal susceptibility...
Guardado en:
Autores principales: | William Hope, Neil R. H. Stone, Adam Johnson, Laura McEntee, Nicola Farrington, Anahi Santoro-Castelazo, Xuan Liu, Anita Lucaci, Margaret Hughes, Jason D. Oliver, Charles Giamberardino, Sayoki Mfinanga, Thomas S. Harrison, John R. Perfect, Tihana Bicanic |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e5efbbfe83444538a96051c24f13cb8a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
por: R. Lu, et al.
Publicado: (2019) -
Antifungal Effects and Potential Mechanisms of Benserazide Hydrochloride Alone and in Combination with Fluconazole Against Candida albicans
por: Chen X, et al.
Publicado: (2021) -
Jjj1 Is a Negative Regulator of Pdr1-Mediated Fluconazole Resistance in <named-content content-type="genus-species">Candida glabrata</named-content>
por: Sarah G. Whaley, et al.
Publicado: (2018) -
A Zinc Cluster Transcription Factor Contributes to the Intrinsic Fluconazole Resistance of <named-content content-type="genus-species">Candida auris</named-content>
por: Eva-Maria Mayr, et al.
Publicado: (2020) -
Potential of Methylglyoxal-Conjugated Chitosan Nanoparticles in Treatment of Fluconazole-Resistant Candida albicans Infection in a Murine Model
por: Khan SH, et al.
Publicado: (2020)